Timeline
Oyster Therapeutics
British protein-degrader biotech targeting tau in Alzheimer's; formerly Kesmalea, raised $60m in 2026.
1 of 1 entries (1 events, 0 interactions)
Filters
#17 10 Nov
British protein-degrader biotech targeting tau in Alzheimer's; formerly Kesmalea, raised $60m in 2026.
1 of 1 entries (1 events, 0 interactions)